Motexafin gadolinium induces mitochondriallymediated caspase-dependent apoptosis
- 1 October 2005
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 10 (5) , 1131-1142
- https://doi.org/10.1007/s10495-005-0887-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumorsExpert Review of Anticancer Therapy, 2004
- Molecular mechanisms of caspase regulation during apoptosisNature Reviews Molecular Cell Biology, 2004
- A serine protease is involved in the initiation of DNA damage-induced apoptosisCell Death & Differentiation, 2003
- The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibitionActa Histochemica, 2001
- Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome cCell Death & Differentiation, 2000
- Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent MannerThe Journal of cell biology, 1999
- Inhibition of Human Caspases by Peptide-based and Macromolecular InhibitorsJournal of Biological Chemistry, 1998
- Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.Proceedings of the National Academy of Sciences, 1996
- Cross-linking of surface IgG induces apoptosis in a bcl-2 expressing human follicular lymphoma line of mature B cell phenotypeInternational Immunology, 1994
- Preclinical Evaluation of Gadolinium (III) Texaphyrin ComplexInvestigative Radiology, 1994